|
"de toledo ra"的相关文件
显示项目 1-2 / 2 (共1页) 1 每页显示[10|25|50]项目
中山醫學大學 |
2021 |
Year-3 Observational Follow-up of Belimumab Safety (Mortality and Malignancies) in Patients with SLE Who Completed a Phase 4, 52-Week, Randomized, Double-Blind Placebo-Controlled Safety Study
|
Sheikh, S; Wei, CC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Kurrasch, R; Fernandes, S; Harris, J; Muzaffar, S; Fox, NL; Liu, A; Quasny, H; Roth, D |
中山醫學大學 |
2021 |
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
|
Sheikh, SZ; Scheinberg, MA; Wei, JCC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MRA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Ros, JO; Levy, RA; Bass, DL; Terres, JR; Punwaney, R; Harris, J; Nami, A; Pierce, A; Thorneloe, KS; Ji, B; Roth, DA |
显示项目 1-2 / 2 (共1页) 1 每页显示[10|25|50]项目
|